| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 01/20/2005 | WO2004083208A8 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 01/20/2005 | WO2004083177A3 Linear chain substituted monocyclic and bicyclic derivatives as factor xa inhibitors |
| 01/20/2005 | WO2004080390A3 Antiprotozoal imidazopyridine compounds |
| 01/20/2005 | WO2003076443A9 Spiro compounds with npy antagonistic activity |
| 01/20/2005 | US20050014942 Transforming growth factor inhibitor; controllign cell differentiation, cell proliferation |
| 01/20/2005 | US20050014939 E.g., N-[4-(2-Pyrrolidinylethoxy)phenyl]-4-oxo-4,5,6,7-tetrahydro-1H-indole-3-carboxamide; treating diseases associated with pathogenic agonism, inverse agonism or antagonism of the GABAA receptor such as anxiety, depression, a sleep disorder, or cognitive impairment |
| 01/20/2005 | US20050014938 Phenyl substituted triazoles and their use as selective inhibitors of akl5 kinase |
| 01/20/2005 | US20050014811 Such as 4-cyclopentylamino-benzenesulfonic acid 2-(3,4-dimethoxy-phenylamino)-1H-benzoimidazol-5-yl ester; cyclin-dependent kinase inhibitors that are aimed to be more active than flavopiridol |
| 01/20/2005 | US20050014805 Hypotensive agents; antidiabetic agents; cardiovascular disorders; anticholesterol agents; anticancer agents |
| 01/20/2005 | US20050014793 Pyridinone derivatives for treatment of atherosclerosis |
| 01/20/2005 | US20050014781 Ring fused pyrazole derivatives as CRF antagonists |
| 01/20/2005 | US20050014780 Process for preparing 5-sulfonamido-8-hydroxy-1,6-naphthyridine-7-carboxamides |
| 01/20/2005 | US20050014778 Variolin derivatives as anti-cancer agents |
| 01/20/2005 | US20050014775 Anticancer agents |
| 01/20/2005 | US20050014771 fused thienopyrimidine compounds useful as phosphatidylinositol 3-kinase inhibitors and carcinostatic agents |
| 01/20/2005 | US20050014759 Substituted 1-benzoyl-3-cyano-pyrrolo [1,2-a] quinolines and analogs as activators of caspases and inducers of apoptosis |
| 01/20/2005 | US20050014758 Derivatives of 3-(guanidinocarbonyl) heterocycle, methods of preparation and intermediates thereof, their use as medicaments, and pharmaceutical compositions therefrom |
| 01/20/2005 | DE10329860A1 Sulfonamidderivate polycyclischer Farbstoffe für analytische Anwendungen Sulfonamide derivatives of polycyclic dyes for analytical applications |
| 01/20/2005 | CA2530589A1 Arylmethyl triazolo and imidazopyrazines as c-met inhibitors |
| 01/20/2005 | CA2530450A1 5-substituted quinazolinone derivatives |
| 01/19/2005 | EP1497294A1 1,2,3,4,7,8-HEXAHYDRO-6 i H /i - 1,4 DIAZEPINO 6,7 ,1- i 1J /i QUINOLINE DERIVATIVES AS ANTIPSYCHOTIC AND ANTI OBESITY AGENTS |
| 01/19/2005 | EP1497293A1 (1,4)diazepino(6,7,1-ij)quinoline derivatives as anti psychotic and antiobesity agents |
| 01/19/2005 | EP1497292A1 Azaindolylpiperidine derivatives as antihistaminic and antiallergic agents |
| 01/19/2005 | EP1497291A2 Quinoline and aza-indole derivatives and their use as 5-ht6 ligands |
| 01/19/2005 | EP1497290A1 Process for preparing acid salts of gemifloxacin |
| 01/19/2005 | EP1497287A1 Quinolinone derivatives |
| 01/19/2005 | EP1497282A2 Inhibitors of serine protease, particularly hepatitis c virus ns3-ns4 protease |
| 01/19/2005 | EP1497279A2 Substituted indoles and their use as 5ht-reuptake inhibitors and as 5ht ligands |
| 01/19/2005 | EP1496906A1 Inhibitors of akt activity |
| 01/19/2005 | EP1496898A2 Tyrosine kinase inhibitors |
| 01/19/2005 | EP1496897A1 Tyrosine kinase inhibitors |
| 01/19/2005 | EP1496896A1 Inhibitors of akt activity |
| 01/19/2005 | EP1496838A2 Substituted amides |
| 01/19/2005 | EP1496836A2 N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as hiv integrase inhibitors |
| 01/19/2005 | EP1377574B1 6-phenylbenzonaphthyridines |
| 01/19/2005 | EP1089988A4 Fluorophenyl resin compounds |
| 01/19/2005 | CN1568324A 1-glyoxylamide indolizines for treating cancer |
| 01/19/2005 | CN1568187A 2H-2, 3-dinitrogen phenodiazine-1-ketone and using method thereof |
| 01/19/2005 | CN1566116A Process for preparing wedelia lactone and application thereof |
| 01/19/2005 | CN1185259C Fluorophenyl resin compounds |
| 01/19/2005 | CN1185233C Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 01/19/2005 | CN1185232C Inhibitors of alpha L beta 2 mediated cell adhesion |
| 01/19/2005 | CN1184968C Antibiotic compositions for treatment of the eye, ear and nose |
| 01/18/2005 | US6844353 Using plant extract effective against botrytis, fursarium and colletotrichum strains |
| 01/18/2005 | US6844342 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents |
| 01/18/2005 | US6844340 Tricyclic 2-pyrimidone compounds useful as HIV reverse transcriptase inhibitors |
| 01/18/2005 | US6844337 1,4-diazabicyclo[3.2.2]nonane-phenylisoxazole derivatives, their preparation and their application in therapeutics |
| 01/18/2005 | US6844089 Organic red electro-luminescent device and dopant |
| 01/18/2005 | US6843979 Radiolabeled compounds useful as imaging agents for visualizing the location and density of serotonin transporter by tomography imaging; as diagnostic and therapeutic agents for diseases associated with serotonin transporter dysfunction |
| 01/13/2005 | WO2005003132A1 Perylenetetracarboxylic acid dibenzimidazole sulfoderivatives containing oxo-groups in the perylene core which form part of a para-quinoid system of bonds, lyotropic liquid crystal systems and anisotropic films containing the same, and methods for making the same |
| 01/13/2005 | WO2005003131A1 Tricyclic delta opioid modulators |
| 01/13/2005 | WO2005003130A1 Novel pyrrolodihydroisoquinolines useful in the treatment of cancer |
| 01/13/2005 | WO2005003129A1 Pyrrolodihydroisoquinolines as pde10 inhibitors |
| 01/13/2005 | WO2005003128A1 Thiazolylpiperidine derivatives as mtp inhibitors |
| 01/13/2005 | WO2005003100A2 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis |
| 01/13/2005 | WO2005003098A1 Heterocyclically substituted pentanol derivatives, method for the production thereof, and use thereof as anti-inflammatory agents |
| 01/13/2005 | WO2005003086A2 Sulfonic acid derivatives of polycyclic dyes used for analytical applications |
| 01/13/2005 | WO2005003065A2 Sulfonamide substituted imidazoquinolines |
| 01/13/2005 | WO2005003064A2 Sulfonamide substituted imidazoquinolines |
| 01/13/2005 | WO2005002503A2 Asymmetric benzimidazoles and related compounds as potassium channel modulators |
| 01/13/2005 | WO2004099134A3 Glutaminyl based dp iv-inhibitors |
| 01/13/2005 | WO2004096805A3 Lyotropic liquid crystal systems based on sulfonated perylenetetracarboxylic acid dibenzimidazoles |
| 01/13/2005 | WO2004087880A8 Compounds and their use to treat diabetes and related disorders |
| 01/13/2005 | WO2004078943A3 Alternative heterocycles for dna recognition |
| 01/13/2005 | WO2004064764A3 Substituted alkyl amido piperidines |
| 01/13/2005 | WO2004050035A3 Benzimidazoles and analogs thereof as antivirals |
| 01/13/2005 | US20050010048 Aza-and polyaza-naphthalenly ketones useful as hiv integrase inhibitors |
| 01/13/2005 | US20050010046 Topoisomerase poison agents |
| 01/13/2005 | US20050009874 Tetrahydropyridin or piperidino heterocyclic derivatives |
| 01/13/2005 | US20050009860 Tricyclic delta-opioid modulators |
| 01/13/2005 | US20050009859 Including multiple sclerosis, atheroslerosis, inflammatory bowel disease, Alzheimer's disease, stroke and diabetes by administering, e.g., 5-pyridin-2-yl-3-trifluoromethyl-1H-pyrazolo[4,3-c]isoquinoline, |
| 01/13/2005 | US20050009854 Triazaspiro compounds useful for treating or preventing pain |
| 01/13/2005 | US20050009852 human orexin receptor antagonists; analgesics, antidiabetic agents; sleep apnea, insomnia |
| 01/13/2005 | US20050009849 Pyridopyrimidine kinase inhibitors |
| 01/13/2005 | US20050009844 Inhibitors of p38 |
| 01/13/2005 | US20050009843 Thiazole derivatives of pyrido-1,2-a-pyrimidines, quinolones, pyridopyridazinoness, cinnolinones and naphthyridones; identifying a drug efflux pump expressed in a microorganism |
| 01/13/2005 | US20050009838 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 01/13/2005 | US20050009830 Fused ring cinnoline derivatives including naphthocinnolines, quinollinocinnolines and naphthopyridinopyridines, e.g., 2,3-Dimethoxydibenzo[ch]cinnoline and 2,3-Dimethoxy-8,9-methylenedioxy-dibenzo[c,h]cinnoline; treatment of anticancer agnets, fungicides and bactericides |
| 01/13/2005 | US20050009829 1-Substituted 2-carboxamide derivatives of fused ring imidazoles, e.g., -[5-(5-Chloro-thiophen-2-yl)-isoxazol-3-ylmethyl]-1H-benzoimidazole-2-carboxylic acid (1-isopropyl-piperidin-4-yl)-amide |
| 01/13/2005 | US20050009828 1-substituted 2-carboxamide derivatives of fused ring pyrroles, especially pyrrolo[2,3-b]pyridines and pyrrolo[3,2-b]pyridines, e.g., 1-[5-(5-Chloro-thiophen-2-yl)-isoxazol-3-ylmethyl]-1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid (1-isopropyl-piperidin-4-yl)-amide |
| 01/13/2005 | US20050009823 E.g., derivatives of pyrazolo[1,5-a]pyrimidines; [1,2,3]triazolo[4,5-b]pyridines; and pyrrolo[3,2-d]pyrimidines and their use as corticotropin releasing factor antagonists |
| 01/13/2005 | US20050009808 Azabicyclo compound matrix metalloprotease inibitor and skin preparation |
| 01/13/2005 | CA2531327A1 Compounds and therapeutical use thereof |
| 01/13/2005 | CA2531060A1 Heterocyclically-substitued pentanol derivatives, process for their production and their use as anti-inflammatory agents |
| 01/13/2005 | CA2530317A1 Pyrrolodihydroisoquinolines useful in the treatment of cancer |
| 01/13/2005 | CA2530316A1 Pyrrolodihydroisoquinolines as pde10 inhibitors |
| 01/13/2005 | CA2529322A1 Sulfonamide substituted imidazoquinolines |
| 01/13/2005 | CA2525580A1 Asymmetric benzimidazoles and related compounds as potassium channel modulators |
| 01/12/2005 | EP1496060A1 Antitumoral analogs of ET-743 |
| 01/12/2005 | EP1495030A1 Non-steroidal progesterone receptor modulators |
| 01/12/2005 | EP1495024A1 Dipyridodiazepinones as reverse transcriptase inhibitors |
| 01/12/2005 | EP1495023A1 Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same |
| 01/12/2005 | EP1495022A1 Diazabicyclo alkane derivatives with nk1 antagonistic activity |
| 01/12/2005 | EP1495017A2 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| 01/12/2005 | EP1495016A2 Heterocyclic compounds and their use as modulators of p38 map kinase |
| 01/12/2005 | EP1494997A1 Substituted aryl amides |
| 01/12/2005 | EP1494673A1 Compounds having unique cb1 receptor binding selectivity and methods for their production and use |
| 01/12/2005 | EP1494671A1 1-(4-piperidinyl)benzimidazolones as histamine h3 antagonists |
| 01/12/2005 | EP1434773A4 Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
| 01/12/2005 | EP1381605B1 Mercaptoacetylamide derivatives, a process for their preparation and their use |